Congenital amegakaryocytic thrombocytopenia (CAMT): a case report with review of literature
- PMID: 17883175
Congenital amegakaryocytic thrombocytopenia (CAMT): a case report with review of literature
Abstract
Congenital amegakaryocytic thrombocytopenia (CAMT) is an uncommon cause of thrombocytopenia in children. Mutations in the thrombopoietin (Tpo) receptor gene C-mpl were found to be the likely cause of thrombocytopenia and complete marrow failure. Two types are identified: CAMT with or without congenital anomalies. We report a case of the latter type for its extreme rarity.
Similar articles
-
[From gene to disease; from a thrombopoietin receptor gene defect to congenital amegakaryocytic thrombocytopenia].Ned Tijdschr Geneeskd. 2002 Mar 9;146(10):469-71. Ned Tijdschr Geneeskd. 2002. PMID: 11913111 Dutch.
-
[Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].Klin Padiatr. 2001 Jul-Aug;213(4):155-61. doi: 10.1055/s-2001-16846. Klin Padiatr. 2001. PMID: 11528548 Review. German.
-
Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.Br J Haematol. 2008 Jun;141(6):808-13. doi: 10.1111/j.1365-2141.2008.07139.x. Epub 2008 Apr 13. Br J Haematol. 2008. PMID: 18422784
-
Congenital amegakaryocytic thrombocytopenia.Pediatr Blood Cancer. 2011 Aug;57(2):199-203. doi: 10.1002/pbc.22927. Epub 2011 Feb 18. Pediatr Blood Cancer. 2011. PMID: 21337678 Review.
-
MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease.Hum Mutat. 2006 Mar;27(3):296. doi: 10.1002/humu.9415. Hum Mutat. 2006. PMID: 16470591